title: Cancer development in pediatric primary renal allograft recipients.
authors.affiliation: Department of Surgery, University of Minnesota, Minneapolis.
authors.forename: S A
authors.initials: SA
authors.lastname: Gruber
authors.forename: K
authors.initials: K
authors.lastname: Gillingham
authors.forename: R B
authors.initials: RB
authors.lastname: Sothern
authors.forename: E
authors.initials: E
authors.lastname: Stephanian
authors.forename: B
authors.initials: B
authors.lastname: Chavers
authors.forename: A J
authors.initials: AJ
authors.lastname: Matas
authors.forename: D L
authors.initials: DL
authors.lastname: Dunn
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D016572:Cyclosporine / Q000009:adverse effects; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D016030:Kidney Transplantation / Q000009:adverse effects* / Q000276:immunology; D008223:Lymphoma / Q000453:epidemiology / Q000209:etiology; D008297:Male; D008910:Minnesota / Q000453:epidemiology; D009369:Neoplasms / Q000453:epidemiology / Q000209:etiology*; D012878:Skin Neoplasms / Q000453:epidemiology / Q000209:etiology
chemical_list: D016572:Cyclosporine